ARCHIVES

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

This article is from The Cancer Letter archive.

Vol. 12 No. 11 | March 14, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

Neuro-Oncologist Schold Leaves Duke For UPCI; Rosner Leads Institute At Chicago.

September 1, 2000

ACCR Considers Foriend Membership, Meeting With ASCO

June 14, 1991

President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money

February 4, 1983

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000